|
|
|
|
Distribution/promotion of Alkeran (melphalan). 31st March 2003. Pharmacopeia Inc ... Alkeran (melphalan). Bifunctional alkylating agent ..
|
|
|
|
|
|
|
In March 2003, Celgene signed an Alkeran supply and distribution agreement with GlaxoSmithKline (GSK:NYSE) to sell the pharmaceutical giant& drug under ..
|
|
|
|
|
|
|
... per diluted share of $0.03 driven by strong Thalomid (thalidomide) and Alkeran (melphalan) tablets and Alkeran (melphalan HCl) for injection sales. ..
|
|
|
|
|
|
|
4) Revenue from Alkeran, the. Anthrogenesis products, and the Ritalin product family may be below expectations. 5). Products in the pipeline could fail in ..
|
|
|
|
|
|
|
by a short-term benefit from CELG& supplier for Alkeran. • However, with a Q105 blended 10% Thalomid price increase, we speculate that ..
|
|
|
|
|
|
|
However, sales of recently in-licensed drug Alkeran (melphalan) were down ... expect some Q-Q choppiness to Alkeran looking forward. On the expense side, ..
|
|
|
|
|
|
|
GOTT I&m a cancer patient who has been prescribed Alkeran Why am I taking ... The major complication of Alkeran is bone mar- row leading to anemia and other ..
|
|
|
|
|
|
|
4) Revenue from Alkeran, the. Anthrogenesis products, and the Ritalin product family may be below expectations. 5). Products in the pipeline could fail in ..
|
|
|
|
|
|
|
ALKERAN sales of $18.3m were in line with 4Q05 sales and more than doubled 1Q05 level. 1. Although significant potential variability remains, ..
|
|
|
|
|
|
|
Raising estimates due to agreement with GlaxoSmithKline for Alkeran; ... Alkeran is a chemotherapy drug currently approved for the treatment of multiple ..
|
|
|
